Literature DB >> 2847473

Monoclonal antibodies against rat adrenocortical cell antigens.

S M Laird1, G P Vinson, B J Whitehouse.   

Abstract

Cell lines secreting antibodies directed against rat adrenocortical cell antigens have been produced using hybridoma techniques. As tested by immunofluorescent staining, eleven of these antibodies were specific for rat adrenocortical cells in that they did not interact with rat adrenal medulla, liver, muscle, ovary or kidney cells. Two of these antibodies were studied in greater detail. One interacted with an antigen present only in adrenal fasciculata and reticularis cells (inner zone antibody, IZA). The expression of the antigen with which this antibody interacted was increased by in vivo treatment with ACTH. The other antibody interacted with an antigen present in all three adrenocortical cell types (adrenocortical antibody ACA). Expression of this antigen was unaffected by ACTH treatment. The effect of both antibodies on steroid biosynthesis by mitochondrial and microsomal preparations of zona glomerulosa and inner zone tissue was tested. For these experiments, the antibodies were purified from culture media by Protein-A-Sepharose affinity chromatography. ACA had no effect on steroidogenesis by any preparation. IZA specifically decreased the production of 18-hydroxydeoxycorticosterone from deoxycorticosterone by the inner zone microsomal and mitochondrial fraction. The results suggest that the IZA antigen is found predominantly in the rat adrenal inner zone and that the antibody may be useful in monitoring adrenocortical zonation. In addition, the antigen would appear to have a functional role in steroid metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847473     DOI: 10.1530/acta.0.1190420

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  7 in total

1.  Distribution of mRNAs encoding classical progestin receptor, progesterone membrane components 1 and 2, serpine mRNA binding protein 1, and progestin and ADIPOQ receptor family members 7 and 8 in rat forebrain.

Authors:  K A Intlekofer; S L Petersen
Journal:  Neuroscience       Date:  2010-10-25       Impact factor: 3.590

Review 2.  PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.

Authors:  Hannah J Rohe; Ikhlas S Ahmed; Katherine E Twist; Rolf J Craven
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

3.  Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure.

Authors:  Mahmoud Reza Mansouri; Jens Schuster; Jitendra Badhai; Eva-Lena Stattin; Ralf Lösel; Martin Wehling; Birgit Carlsson; Outi Hovatta; Per Olof Karlström; Irina Golovleva; Daniela Toniolo; Silvia Bione; John Peluso; Niklas Dahl
Journal:  Hum Mol Genet       Date:  2008-09-09       Impact factor: 6.150

Review 4.  Expression, localization and possible actions of 25-Dx, a membraneassociated putative progesterone-binding protein, in the developing Purkinje cell of the cerebellum: a new insight into the biosynthesis, metabolism and multiple actions of progesterone as a neurosteroid.

Authors:  Hirotaka Sakamoto; Kazuyoshi Ukena; Mitsuhiro Kawata; Kazuyoshi Tsutsui
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

5.  Long-term incubation with mifepristone (MLTI) increases the spine density in developing Purkinje cells: new insights into progesterone receptor mechanisms.

Authors:  Lisa Wessel; Ajeesh Balakrishnan-Renuka; Corinna Henkel; Helmut E Meyer; Karl Meller; Beate Brand-Saberi; Carsten Theiss
Journal:  Cell Mol Life Sci       Date:  2013-08-28       Impact factor: 9.261

Review 6.  Functional Zonation of the Adult Mammalian Adrenal Cortex.

Authors:  Gavin P Vinson
Journal:  Front Neurosci       Date:  2016-06-15       Impact factor: 4.677

Review 7.  Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450.

Authors:  Chang S Ryu; Kathrin Klein; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2017-03-27       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.